Viz.ai has announced the US commercial launch of its AI-powered modules for pulmonary embolism and aortic disease. Debuting at VEITHsymposium 2021 (16–20 November, Orlando, USA), the new modules allow for faster clinical decision-making and improved care coordination for patients suffering from these two life-threatening conditions, a press release details.
The new modules leverage advanced deep learning to communicate time-sensitive information, including advanced imaging studies and real time clinical information, to specialists who can more quickly and easily make treatment decisions for the patient, the press release continues. Users can access all aortic and pulmonary imaging from the cloud.
“This technology has changed the way we triage and treat stroke patients, dramatically improving their care,” said Richard Saxon, interventional radiologist at Tri-City and Palomar Health, San Marcos, USA. “In a similar fashion, I believe the Viz.ai PE and Aortic modules will enhance image interpretation with AI [artificial intelligence], dramatically improve the quality and speed of mobile image viewing, and improve caregiver communication. This is truly the care coordination of the future.”
According to Viz.ai, the company has accelerated the time-to-notification of the treatment team by 73% and time-to-treatment by 24%.
“The launch of these two new modules brings the power of the Viz platform to a vast new faction of medical professionals and patients battling life-threatening conditions,” said Chris Mansi, Viz.ai CEO and cofounder. “This is a significant milestone in our mission to fundamentally improve how healthcare is delivered in the world.”
Viz.ai will be showcasing the new AI-powered PE and aortic disease modules at VEITHsymposium Booth #317.